PMN experienced a dramatic financial deterioration with stockholders' equity turning negative, massive losses, and outstanding shares plummeting from 32.7M to 9.0M, suggesting a potential reverse stock split amid severe capital constraints.
The company's financial position has collapsed with stockholders' equity going from positive $16.5M to negative $1.3M, indicating potential insolvency risk. The 73% reduction in outstanding shares (32.7M to 9.0M) likely reflects a reverse stock split to maintain listing compliance, while the removal of going concern language appears inconsistent with the deteriorating fundamentals and may warrant scrutiny.
PMN's financials show severe deterioration across all metrics, with net income swinging from positive $2.8M to a massive loss of $39.7M driven by R&D expenses tripling to $33.4M. The balance sheet contracted sharply with total assets falling 51% to $9.2M, cash burning down 54% to $6.1M, while liabilities surged over 300% to $10.4M, resulting in negative stockholders' equity. This financial profile suggests a company in distress, burning through capital rapidly while advancing clinical programs, creating urgent need for additional financing to avoid potential bankruptcy.
Net income declined 1529.3% — review whether driven by operations, interest costs, or non-recurring items.
Current liabilities surged 369.3% — significant near-term obligations; verify ability to meet short-term debt.
Liabilities grew 330.9% — significant increase in debt or obligations, assess impact on financial flexibility.
R&D investment increased 213.8% — signals commitment to future product development, though near-term margin impact.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Capex reduced 67.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash declined 54% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Total assets contracted 51.4% — asset sales, write-downs, or balance sheet optimization underway.
Current assets declined 51.4% — monitor working capital adequacy and short-term liquidity.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →